Cellarity's CEO on harnessing technology to better understand disease from a whole cell approach
- blonca9
- Mar 5, 2024
- 1 min read
Fabrice Chouraqui describes Cellarity's platform and how it is being put to use for indications such as sickle cell disease and MASH.